These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36542467)

  • 1. [Diagnostic performance of the FINDRISC questionnaire to identify insulin resistance in adults].
    Varela-Vega Y; Roy-García IA; Pérez-Rodríguez M; Velázquez-López L
    Rev Med Inst Mex Seguro Soc; 2023 Jan; 61(1):33-41. PubMed ID: 36542467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the Finnish Diabetes Risk Score (FINDRISC), vitamin D levels, and insulin resistance in obese subjects.
    Lima-Martínez MM; Arrau C; Jerez S; Paoli M; González-Rivas JP; Nieto-Martínez R; Iacobellis G
    Prim Care Diabetes; 2017 Feb; 11(1):94-100. PubMed ID: 27914905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care.
    Lim HM; Chia YC; Koay ZL
    Prim Care Diabetes; 2020 Oct; 14(5):494-500. PubMed ID: 32156516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
    Vandersmissen GJ; Godderis L
    Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America.
    Lima-Martínez MM; Colmenares L; Campanelli Y; Paoli M; Rodney M; Santos RD; Iacobellis G
    Clin Investig Arterioscler; 2019; 31(1):15-22. PubMed ID: 30166212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
    Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
    Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population.
    Rokhman MR; Arifin B; Zulkarnain Z; Satibi S; Perwitasari DA; Boersma C; Postma MJ; van der Schans J
    PLoS One; 2022; 17(7):e0269853. PubMed ID: 35862370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe.
    Gabriel R; Acosta T; Florez K; Anillo L; Navarro E; Boukichou N; Acosta-Reyes J; Barengo NC; Lindström J; Tuomilehto JO; Aschner P
    Diabetes Res Clin Pract; 2021 Aug; 178():108976. PubMed ID: 34302911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FINDRISC as screening for detection of prediabetes and unknown type 2 diabetes].
    Peralta HM; Costa Gil JE; Saleme AE
    Medicina (B Aires); 2024; 84(1):1-10. PubMed ID: 38271927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a Finnish Diabetes Risk Score in detecting undiagnosed diabetes among Kenyans aged 18-69 years.
    Mugume IB; Wafula ST; Kadengye DT; Van Olmen J
    PLoS One; 2023; 18(4):e0276858. PubMed ID: 37186010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.
    Schwarz PE; Li J; Reimann M; Schutte AE; Bergmann A; Hanefeld M; Bornstein SR; Schulze J; Tuomilehto J; Lindström J
    J Clin Endocrinol Metab; 2009 Mar; 94(3):920-6. PubMed ID: 19106274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population.
    Jin S; Chen Q; Han X; Liu Y; Cai M; Yao Z; Lu H
    Front Endocrinol (Lausanne); 2022; 13():725314. PubMed ID: 35273562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.
    Muñoz-González MC; Lima-Martínez MM; Nava A; Trerotola G; Paoli M; Cabrera-Rego JO; Gonzalez B; Arciniegas A; Paez J
    Med Princ Pract; 2019; 28(4):324-332. PubMed ID: 30852570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study.
    Jølle A; Midthjell K; Holmen J; Carlsen SM; Tuomilehto J; Bjørngaard JH; Åsvold BO
    BMJ Open Diabetes Res Care; 2019; 7(1):e000769. PubMed ID: 31803483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the Finnish Diabetes Risk Score for Predicting Diabetes Incidence in People Living with HIV.
    Galaviz KI; Schneider MF; Tien PC; Althoff KN; Ali MK; Ofotokun I; Brown TT
    AIDS Res Hum Retroviruses; 2021 May; 37(5):373-379. PubMed ID: 33683149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in Kayseri, Turkey.
    Atayoglu AT; Inanc N; Başmisirli E; Çapar AG
    Prim Care Diabetes; 2020 Oct; 14(5):488-493. PubMed ID: 32029385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.
    Costa B; Barrio F; Piñol JL; Cabré JJ; Mundet X; Sagarra R; Salas-Salvadó J; Solà-Morales O;
    BMC Med; 2013 Feb; 11():45. PubMed ID: 23438147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the Finnish diabetes risk score in Venezuela using a national sample: The EVESCAM.
    Nieto-Martínez R; González-Rivas JP; Ugel E; Marulanda MI; Durán M; Mechanick JI; Aschner P
    Prim Care Diabetes; 2019 Dec; 13(6):574-582. PubMed ID: 31202539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.